Stephen Squinto

2020

In 2020, Stephen Squinto earned a total compensation of $3.8M as Former Interim Chief Executive Officer and former Acting Head of Research and Development at Passage BIO, a 76% increase compared to previous year.

Compensation breakdown

Option Awards$2,977,939
Salary$246,000
Other$540,993
Total$3,764,932

Squinto received $3M in option awards, accounting for 79% of the total pay in 2020.

Squinto also received $246K in salary and $541K in other compensation.

Rankings

In 2020, Stephen Squinto's compensation ranked 3,064th out of 13,090 executives tracked by ExecPay. In other words, Squinto earned more than 76.6% of executives.

ClassificationRankingPercentile
All
3,064
out of 13,090
77th
Division
Manufacturing
1,192
out of 5,624
79th
Major group
Chemicals And Allied Products
453
out of 2,257
80th
Industry group
Drugs
392
out of 1,957
80th
Industry
Biological Products, Except Diagnostic Substances
99
out of 411
76th
Source: SEC filing on April 14, 2021.

Squinto's colleagues

We found three more compensation records of executives who worked with Stephen Squinto at Passage BIO in 2020.

2020

Bruce Goldsmith

Passage BIO

Chief Executive Officer

2020

Jill Quigley

Passage BIO

Chief Operating Officer

2020

Gary Romano

Passage BIO

Chief Medical Officer

News

In-depth

You may also like